Manchester City Injury Update: Haaland, De Bruyne, and Ederson’s Return Dates Revealed

As Manchester City prepares for a crucial phase in their season, injury concerns loom over key players Erling Haaland, Kevin De Bruyne, and Ederson, with Pep Guardiola awaiting fitness updates during the March international break.

Manchester City Injury Update and Return Dates

Erling Haaland

Erling Haaland, who has emerged as a potential injury doubt, was observed struggling in training for Norway, sparking fears of an impending setback.

His participation in Norway’s upcoming friendly matches against Czechia and Slovakia will provide clarity on his fitness status. The striker’s potential return date is slated for City’s clash against Arsenal on March 31.

Potential return date: Arsenal (H) – March 31

Kevin De Bruyne

Meanwhile, Kevin De Bruyne missed City’s recent FA Cup victory over Newcastle United due to a groin injury, subsequently prompting his withdrawal from the Belgium squad.

De Bruyne will spend the next week recuperating from the injury, with Guardiola expected to provide further updates on his availability next week. The midfielder’s potential return is anticipated for late March or early April.

Potential return date: Late March/early April

Also Read: Manchester City Await Verdict on 115 FFP Charges Amid Everton and Nottingham Forest Penalties

Ederson

In addition, goalkeeper Ederson has been sidelined with a leg injury sustained during City’s encounter with Liverpool on March 10.

Although initially expected to be out for three to four weeks, there is optimism regarding his potential return for the Arsenal fixture, marking the first game back after the international break on March 31.

Potential return date: Arsenal (H) – March 31

As City gears up for the resumption of Premier League action and their pursuit of success in multiple competitions, Guardiola and the club’s medical staff will closely monitor the progress of Haaland, De Bruyne, and Ederson in the hopes of swiftly reintegrating them into the squad.